---
title: "AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283399276.md"
datetime: "2026-04-20T20:35:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283399276.md)
  - [en](https://longbridge.com/en/news/283399276.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283399276.md)
---

# AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies

April 20 (Reuters) - AN2 Therapeutics Inc (ANTX.O) : \* AN2 THERAPEUTICS INC - ENTERS OPEN MARKET SALE AGREEMENT WITH JEFFERIES LLC DATED APRIL 9, 2026 - SEC FILING \* AN2 THERAPEUTICS INC - MAY OFFER AND SELL COMMON STOCK UP TO $80 MILLION THROUGH JEFFERIES - SEC FILING Source text: Further company coverage: (ANTX.O)

### Related Stocks

- [ANTX.US](https://longbridge.com/en/quote/ANTX.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)

## Related News & Research

- [Veradermics Announces Launch of Public Offering | MANE Stock News](https://longbridge.com/en/news/284272437.md)
- [Align Technology Announces $200 Million Open Market Repurchase | ALGN Stock News](https://longbridge.com/en/news/284882063.md)
- [Deutsche Boerse CEO warns against 24/7 trading as Wall Street gears up for it](https://longbridge.com/en/news/284166812.md)
- [CoreWeave Insider Sold Shares Worth $31,346,733, According to a Recent SEC Filing](https://longbridge.com/en/news/284716257.md)
- [Table-Non-competitive bids for U.S. 6-week bills](https://longbridge.com/en/news/284414361.md)